Why is Sai Parenterals Ltd ?
1
Weak Long Term Fundamental Strength with an average Return on Capital Employed (ROCE) of 5.37%
- Poor long term growth as Net Sales has grown by an annual rate of 57.40% and Operating profit at -0.88% over the last 5 years
- High Debt Company with a Debt to Equity ratio (avg) at 0 times
2
With ROE of 2.9, it has a Very Expensive valuation with a 4.3 Price to Book Value
3
Falling Participation by Institutional Investors
- Institutional investors have decreased their stake by -1.87% over the previous quarter and collectively hold 10.69% of the company
- These investors have better capability and resources to analyse fundamentals of companies than most retail investors
How much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
No Data Found
Quality key factors
Factor
Value
Sales Growth (5y)
57.40%
EBIT Growth (5y)
-0.88%
EBIT to Interest (avg)
1.93
Debt to EBITDA (avg)
9.14
Net Debt to Equity (avg)
0.49
Sales to Capital Employed (avg)
0.45
Tax Ratio
Tax Ratio is Negative%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
10.69%
ROCE (avg)
4.16%
ROE (avg)
2.91%
Valuation Key Factors 
Factor
Value
P/E Ratio
86
Industry P/E
40
Price to Book Value
4.34
EV to EBIT
109.57
EV to EBITDA
61.86
EV to Capital Employed
3.23
EV to Sales
6.28
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
2.95%
ROE (Latest)
2.88%
Loading Valuation Snapshot...
19What is working for the Company
OPERATING CF(Y)
Highest at Rs 93.05 Cr
PAT(Q)
At Rs 10.51 cr has Grown at 102.4% (vs previous 4Q average
NET SALES(Q)
At Rs 194.92 cr has Grown at 48.1% (vs previous 4Q average
PBDIT(Q)
Highest at Rs 40.24 cr.
-3What is not working for the Company
INTEREST(Latest six months)
At Rs 18.34 cr has Grown at 32.80%
NON-OPERATING INCOME(Q)
is 37.61 % of Profit Before Tax (PBT
Loading Valuation Snapshot...
Here's what is working for Sai Parenteral's
Profit After Tax (PAT) - Quarterly
At Rs 10.51 cr has Grown at 102.4% (vs previous 4Q average)
over average PAT of the previous four quarters of Rs 5.19 CrMOJO Watch
Near term PAT trend is very positive
PAT (Rs Cr)
Operating Cash Flow - Annually
Highest at Rs 93.05 Cr and Grown
each year in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (Rs Cr)
Net Sales - Quarterly
At Rs 194.92 cr has Grown at 48.1% (vs previous 4Q average)
over average Net Sales of the previous four quarters of Rs 131.57 CrMOJO Watch
Near term sales trend is very positive
Net Sales (Rs Cr)
Operating Profit (PBDIT) - Quarterly
Highest at Rs 40.24 cr.
in the last five quartersMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (Rs Cr)
Here's what is not working for Sai Parenteral's
Interest - Latest six months
At Rs 18.34 cr has Grown at 32.80%
over previous Half yearly periodMOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (Rs cr)
Non Operating Income - Quarterly
is 37.61 % of Profit Before Tax (PBT)
MOJO Watch
The company's income from non business activities is high; which is not a sustainable business model
Non Operating Income to PBT